Ampio Pharmaceuticals Inc (AMPE) Return on Investment ROI from the fourth quarter of 2023 to fourth quarter of 2022 and for the year 2023, average high and low, overall ranking from Dec 31 2023 to Dec 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ampio Pharmaceuticals inc   (NYSEAMER: AMPE)


Ampio Pharmaceuticals Inc's ROI from its fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Ampio Pharmaceuticals Inc's ROI in the fourth quarter of 2023?
Ampio Pharmaceuticals Inc recorded a cumulative net loss of $-9 million during 12 months ending in the fourth quarter of 2023, resulting in a negative return on investment (ROI) of -147.23%.

Within the Healthcare sector 805 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2023 from 4240 to 4590.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Investment Change TTM -69.42 % -66.85 % -59.27 % -44.98 % -21.21 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 3 5 7 8 12
Return On Investment (TTM) -147.23 % -108.32 % -133.06 % -102.1 % -85.2 %
AMPE's Overall Ranking # 4590 # 4240 # 4555 # 4385 # 4587
Seq. Investment Change TTM -27.81 % -22.7 % -26.92 % -25.03 % -21.74 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -9 -9 -14 -15 -16

AMPE Company Profile >> Back to AMPE Roi Comparisons >> See Annual AMPE Return On Investment



Return On Investment AMPE's Ranking
Within: No.
Industry # 387
Sector # 806
Overall # 4590

Return On Investment Statistics
High Average Low
295.06 %
-96.29 %
-558.31 %
(Dec 31 2018)   (Dec 31 2017)







Financial Statements
Ampio Pharmaceuticals Inc's IV. Quarter Investments $ 3 Millions AMPE's Balance sheet
Ampio Pharmaceuticals Inc's IV. Quarter Income $ -2 Millions Quarterly AMPE's Income Statement
AMPE's Income by Division See AMPE's Income by Division


AMPE Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions 3 12 34 21 10
Y / Y Investment Growth -72.89 % -63.22 % 60.15 % 116.57 % -23.16 %
Net Income in Millions -9 -16 -17 -16 -14
Y / Y Net Income Growth - - - - -
Annual Return On Investment -256.9 % -131.79 % -50.66 % -75.53 % -140.27 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AMPE's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AMPE's Competitors
Subscribers only: Roi for Ampio Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for AMPE's Customers

Other Ratios
AMPE's Roa AMPE's Inventory Turnover Ratio AMPE's Growth Rates AMPE's Dividend Statistics
AMPE's Profitability Ratios AMPE's Asset Turnover Ratio AMPE's Dividend Growth
AMPE's Roe AMPE's Valuation Ratios AMPE's Financial Strength Ratios AMPE's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2023, within Healthcare Sector ROI

Date modified: 2026-09-08T15:11:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.